Synapse - Stephen Nimer

Results (25)

Genetic uncoupling of the regulation of hematopoietic stem cell quiescence and self-renewal

Meeting Abstract

Liu, Y.; Miyata, Y.; Sashida, G.; Deblasio, A.; Liu, Y. H.; Koff, A.; Nimer, S. D.
Blood (2006)

Long-term clinical benefit of lenalidomide (Revlimid) treatment in patients with Myelodysplastic syndrome and chromosome deletion 5q

Meeting Abstract

List, A. F.; Dewald, G. W.; Bennett, J. M.; Giagounidis, A.; Raza, A.; Feldman, E. J.; Powell, B. L.; Greenberg, P. L.; Nimer, S. D.; Zeldis, J. B.; more...
Blood (2006)

Fulltext@MSK | Save

The role of cyclin C on hematopoietic cells

Meeting Abstract

Lie, Y.; Sashida, G.; Nimer, S.; Miyata, Y.
Blood (2006)

Fulltext@MSK | Save

Identification of key cellular regulators that interact with Id1 to control hematopoietic stem cell behavior

Meeting Abstract

Jankovic, V.; Ciarrocchi, A.; Deblasio, T.; Benezra, R.; Nimer, S. D.
Blood (2006)

Fulltext@MSK | Save

The deletion of NHR1 region of the AML1-ETO protein significantly decreases its ability to promote proliferation and self-renewal of early hematopoietic cells in culture

Meeting Abstract

Gural, A.; Jankovic, V.; Zhang, J.; Roeder, R. G.; Nimer, S. D.
Blood (2006)

Fulltext@MSK | Save

Mobilization of blood stem cells with G-CSF in systemic light-chain amyloidosis: Dominant organ involvement significantly affects stem cell collection

Meeting Abstract

Comenzo, R.; Hassoun, H.; Reich, L.; Collins, N.; Nuta, A.; Chen, X. S.; Zhou, P.; Clark, B.; Teruya-Feldstein, J.; Fleisher, M.; more...
Blood (2006)

Fulltext@MSK | Save

Risk-adapted melphalan (MEL) with stem cell transplant (SCT) and adjuvant dexamethasone (D)+/- thalidomide (T) for AL patients achieves low treatment-related mortality (TRM) and high hematologic response rates

Meeting Abstract

Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Clark, B.; Stubblefield, M.; Fleisher, M.; Nimer, S. D.; more...
Amyloid (2006)

Fulltext@MSK | Save

Induction of remission prior to transplantation improves the disease-free survival (DFS) of patients with advanced myelodysplastic syndromes (MDS) treated with myeloablative T - Cell depleted (TCD) stem cell transplants (SCT) from histocompatible unrelated donors

Meeting Abstract

Castro-Malaspina, H. R.; Jakubowski, A. A.; Papadopoulos, E. B.; Boulad, F.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Chiu, M.; Heller, G.; more...
Blood (2006)

Fulltext@MSK | Save

CD32B on clonal plasma cells in systemic light-chain amyloidosis (AL) and multiple myeloma (MM): A target for immunotherapy in both disorders and a prognostic marker in MM